Tag Archives: Lilly’s

Eli Lilly’s Olympics campaign rewind: Leverage pandemic’s focus on health to assert its brand and assert its point of view

When Eli Lilly signed on to be an Olympic sponsor for the Tokyo Games in 2019, the pandemic was of course yet to come. When COVID-19 did hit, the Games were postponed and the newly busy pharma industry dove into researching vaccines and therapies. But as successful vaccines and monoclonal antibody treatments came to market,… Read More »

Lilly’s Taltz (ixekizumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis

Print this page INDIANAPOLIS, March 30, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for Taltz (ixekizumab) injection, 80 mg/mL for the treatment of pediatric patients (ages 6 to under 18) with moderate to severe plaque psoriasis… Read More »